Accepted answer
95.2 and 96.8 are 1.6 percentage points apart, which sounds small until you restate it as impurity. Medutest is leaving 4.8 per cent of the detected area unassigned and Janoshik 3.2 per cent — a factor of 1.5 between them. The impurity fraction is the quantity that moves when a method changes, and it is the one worth arguing about; the headline is just its complement. Comparable means same column chemistry, same gradient slope, same detection wavelength, same integration convention. Until you have those four from both laboratories, 95.2 and 96.8 are two measurements of slightly different quantities that happen to share a unit.
Gradient slope is the most powerful parameter and almost nobody mentions it, which is why two reports on the same material disagree by a point.
Tailing factor measures peak shape, and a badly tailing peak spreads into the region where small impurities live, forcing tangent-skim integration that assigns tail area to the main peak.
Put another way, buffer versus acid in the mobile phase changes the ionisation state of basic and acidic residues, shifting retention and selectivity — same vial, potentially different separation.
The ICH Q3A impurity thresholds and the relevant pharmacopoeial chapters all specify method validation requirements that almost no research-grade certificate claims to meet.
If you are ranking vendors, specify a method and have all samples tested at the same place.
7Confirming from the other direction: I ignored the method section once and paid for it. – a_lindgren 3 months ago 6The distinction between purity and content cannot be repeated often enough here. – RP_C18 2 months ago add a comment